Latest News | Dr Reddy's Launches Stomach, Esophagus Problems Treatment Drug in the US
Get latest articles and stories on Latest News at LatestLY. Drug major Dr Reddy's Laboratories on Monday said it has launched Lansoprazole delayed release orally disintegrating tablets, used to treat certain stomach and esophagus problems , in the US market.
New Delhi, Feb 22 (PTI) Drug major Dr Reddy's Laboratories on Monday said it has launched Lansoprazole delayed release orally disintegrating tablets, used to treat certain stomach and esophagus problems , in the US market.
The product is a therapeutic equivalent generic version of Prevacid SoluTab delayed release orally disintegrating tablets approved by the US Food and Drug Administration (USFDA).
In a regulatory filing, Dr Reddy's laboratories announced launch of Lansoprazole DR (delayed release) orally disintegrating tablets.
Quoting IQVIA Health data, Dr Reddy's said the Prevacid brand and generic had US sales of approximately USD 87 million for the most recent 12 months ending in December 2020.
Dr Reddy's Lansoprazole DR orally disintegrating tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100.
Shares of Dr Reddy's Laboratories were trading 1.50 per cent lower at Rs 4,615 apiece on BSE.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)